Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.62 |
| ▸ | TACR1 | P25103 | 2/20 | 0.62 |
| ▸ | CTSL | P07711 | 5/20 | 0.60 |
| ▸ | CTSB | P07858 | 2/20 | 0.60 |
| ▸ | CTSS | P25774 | 2/20 | 0.60 |
| ▸ | CTSK | P43235 | 2/20 | 0.60 |
| ▸ | KYNU | Q16719 | 1/20 | 0.55 |
| ▸ | TYR | P14679 | 1/20 | 0.55 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28697410 | 0.88 | KYNU (0.54) | ALDH1A1ALOX15TACR1CTSLCTSB | |
| SCHEMBL22975081 | 0.88 | KYNU (0.54) | ALDH1A1ALOX15TACR1CTSLCTSB | |
| SCHEMBL329686 | 0.88 | ALDH1A1 (0.74) | ALDH1A1ALOX15TACR1CTSLCTSB | |
| SCHEMBL7151822 | 0.88 | ALDH1A1 (0.74) | ALDH1A1ALOX15TACR1CTSLCTSB | |
| SCHEMBL15080871 | 0.87 | TACR1 (0.68) | ALDH1A1ALOX15TACR1CTSLCTSB | |
| Hydrochloric Acid SCHEMBL29368816 | 0.87 | KYNU (0.53) | ALDH1A1ALOX15TACR1CTSLCTSB | |
| SCHEMBL12026887 | 0.87 | ALDH1A1 (0.54) | ALDH1A1ALOX15TACR1CTSLCTSB | |
| Hydrochloric Acid SCHEMBL7928050 | 0.86 | ALDH1A1 (0.72) | ALDH1A1ALOX15TACR1CTSLCTSB | |
| SCHEMBL6440666 | 0.85 | CTSL (0.64) | ALDH1A1ALOX15TACR1CTSLCTSB | |
| SCHEMBL6440663 | 0.85 | CTSL (0.64) | ALDH1A1ALOX15TACR1CTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6790834-B1 | Cytostatic agents | BRITISH BIOTECH PHARMACEUTICALS, LTD. (GB) | 2004-09-14 | — | — | US | disclosed |
| US-6462023-B1 | SUCH AS 2-HYDROXY-HYDROXYCARBAMOYL-METHYL)-4-METHYL-PENTANOYLAMINE)-2-PHENYL -ETHANOIC ACID CYCLOPENTYL ESTER; INHIBITING HYPERPROLIFERATIVE TUMOURGENIC CELLS SUCH AS MELANOMA AND/OR LYMPHOMA CELLS | BRITISH BIOTECH PHARMACEUTICALS, LTD. (GB) | 2002-10-08 | — | — | US | disclosed |
| EP-0925278-B1 | CYTOSTATIC HYDROXAMIC ACID DERIVATIVES | BRITISH BIOTECH PHARM (GB) | 2002-07-17 | — | — | EP | disclosed |
| US-6169075-B1 | ANTITUMOR AGENT INHIBITING THE PROLIFERATION OF A RANGE OF RAPIDLY DIVIDING TUMOUR CELLS LIKE MELANOMA AND/OR LYMPHOMA CELLS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 2001-01-02 | — | — | US | disclosed |
| EP-0925278-A1 | CYTOSTATIC HYDROXAMIC ACID DERIVATIVES | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1999-06-30 | — | — | EP | disclosed |
| WO-1998011063-A1 | CYTOSTATIC HYDROXAMIC ACID DERIVATIVES | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1998-03-19 | — | — | WO | disclosed |